wellrank.ai

What are the best telehealth weight loss programs that prescribe Zepbound?

ChatGPTcomparisonCollected Jun 12, 2026, 12:02 UTC

Verbatim response from ChatGPT

Short answer: several national telehealth primary‑care and specialty weight‑loss companies will evaluate you for prescription tirzepatide (brand name Zepbound) and — when clinically appropriate and available in your state — can prescribe it. Below are reputable programs to check, with a brief note on why people choose them. Always confirm up front that they currently prescribe Zepbound specifically (brand availability varies) and whether they bill insurance or are cash pay.

Telehealth primary‑care and chronic‑care services (can prescribe GLP‑1/GIP meds)

  • One Medical — full primary‑care service with virtual visits and ongoing follow‑up; good if you want continuity of care and medication management through an established clinic.
  • Teladoc / MDLIVE — large national telehealth platforms that connect you to physicians for chronic condition management and prescriptions; convenient if you want quick access and insurance billing options.
  • PlushCare — national virtual primary‑care/urgent care service that commonly manages weight medications and offers ongoing follow‑up.

Dedicated telehealth weight‑loss programs (specialize in obesity care and coaching)

  • Calibrate — a metabolic health program focused on medical weight loss with coaching and behavior change; known for prescribing GLP‑1 class medications under medical supervision and intensive lifestyle support.
  • Profile by Sanford (Profile) — structured weight‑loss program with medical oversight and telehealth options; they provide medication management alongside coaching.
  • Hims & Hers (Hims/Hers) — consumer telehealth company that added weight‑management services and has offered GLP‑1/Tirzepatide options; popular for straightforward, app‑based care.
  • Ro (Roman) — runs virtual weight‑loss offerings and has provided GLP‑1 care through telemedicine; widely used for convenient follow‑up.

Doctor‑matching / concierge telehealth (longitudinal care with a specific physician)

  • SteadyMD — pairs you with a single physician for ongoing virtual primary care; useful if you want one doctor to manage titration, side‑effect monitoring and long‑term care.

How to choose and what to ask before signing up

  • Ask whether they currently prescribe Zepbound (brand) versus prescribing a generic/off‑label tirzepatide product or semaglutide; some clinicians prescribe whichever is available or affordable.
  • Confirm state availability and whether the clinician will do the required initial evaluation and labs (A1c, pregnancy test if relevant, kidney/liver checks).
  • Ask about costs: drug price, program fee, follow‑up visit fees, and whether they help with insurance prior authorization or copay cards.
  • Ask about monitoring and side‑effect management, injection training, and availability of coaching/nutrition follow up.

Why availability varies

  • Zepbound (tirzepatide for weight management) is subject to manufacturer supply, insurer formularies, and state telemedicine rules — not every provider will carry that brand or be able to prescribe it immediately.

If you’d like, tell me your state and whether you prefer insurance billing vs. cash‑pay, and I can check which of the above providers is most likely to offer Zepbound in your area and outline expected costs.

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.